17796669065  396269538@qq.com

Industry news

TENS Electrode Patches: How Transcutaneous Electrical Nerve Stimulation Differs from Chemical Pain Patches

Industry news 2026-07-17 11:00:00 43 views admin

TENS Electrode Patches: How Transcutaneous Electrical Nerve Stimulation Differs from Chemical Pain Patches

Best for: trapezius spasm and tech-neck tension, post-exercise muscle soreness, menstrual cramp pain, acute sports injury recovery, diabetic neuropathy adjunct, and chronic low back pain where chemical analgesics are contraindicated.

Hero image for tens_electrode_patch_minimax

TENS (transcutaneous electrical nerve stimulation) electrode patches deliver pulsed electrical current through hydrogel-adhesive electrodes rather than pharmacological actives. The mechanism is fundamentally different from menthol, lidocaine, methyl salicylate, or capsaicin: TENS modulates pain signals through spinal gating and descending inhibitory pathways, not through receptor binding or substance depletion. This article walks through the engineering, the clinical-evidence base, and the B2B spec sheet a private-label brand owner needs to brief an OEM factory.

What is TENS, and how does a TENS electrode patch work?

A TENS system has three components: a pulse generator (a small battery-powered controller, often the size of a deck of cards), lead wires, and a pair of electrode patches that adhere to the skin. The patches themselves are passive — they deliver current to the skin but contain no active pharmaceutical ingredient. The TENS effect is achieved by adjusting pulse frequency, pulse width, and intensity on the controller.

Two principal mechanisms produce analgesia:

  • High-frequency TENS (50-150 Hz) - activates large-diameter A-beta sensory fibers, which "close the gate" on pain signals carried by small-diameter C and A-delta fibers at the spinal dorsal horn. Effect is felt within minutes; ceases when stimulation stops.
  • Low-frequency TENS (1-10 Hz) - triggers release of endogenous opioids (beta-endorphin, met-enkephalin) and serotonin in the spinal cord and brainstem. Effect builds over 20-30 minutes; produces residual analgesia for 30-60 minutes after stimulation stops.

Most consumer TENS units allow the user to switch between high-frequency and low-frequency modes, and to combine them in alternating patterns. The electrode patch itself does not change — only the controller settings.

TENS electrode patches versus chemical analgesic patches: which to use when

ParameterTENS electrode patchChemical analgesic patch (menthol / lidocaine / etc.)
MechanismElectrical modulation of spinal pain gatingReceptor binding (TRPM8 / Na+ channels / COX)
Onset of reliefImmediate (during stimulation)1-60 minutes (depends on active)
Duration of effectDuring stimulation + 30-60 min after (low-freq mode)Continuous during wear (4-12 h)
Active ingredientNone (electrical only)Menthol / lidocaine / capsaicin / methyl salicylate
Skin toleranceGenerally well tolerated; mild redness possibleVariable; menthol and capsaicin can irritate
Drug interactionsNoneMethyl salicylate - warfarin / aspirin; lidocaine - antiarrhythmics
PregnancyUse with obstetrician guidanceGenerally avoided for methyl salicylate and capsaicin
Required hardwareTENS controller + lead wiresNone (self-contained)
Cost per useLow (electrode reusable 20-50 times)Higher (single-use per patch)
Regulatory category (US)Class II medical device (FDA 510(k))Cosmetic / OTC monograph / structure-function
Best forAcute muscle spasm, post-exercise, drug interaction patientsSustained background relief during daily activities

Clinical-evidence base for TENS in pain management

TENS has one of the strongest evidence bases of any non-pharmacological pain intervention. The 2019 Cochrane review (Gibson et al., Cochrane Database of Systematic Reviews, CD011058) concluded that high-frequency TENS produced clinically meaningful pain relief in acute pain conditions (NNT 2.4 versus placebo) and chronic musculoskeletal pain (NNT 3.1). For chronic neuropathic pain, the evidence is more mixed but generally positive, particularly when combined with conventional analgesic therapy.

IndicationEvidence levelNotes
Acute post-operative painStrong (Cochrane 2019 NNT 2.4)Reduces opioid requirement
Chronic musculoskeletal pain (low back, neck, knee)Moderate-strong (NNT 3.1)Best as adjunct to exercise therapy
DysmenorrheaModerate (Cochrane 2009 review)High-frequency mode most effective
Diabetic peripheral neuropathyMixed-positiveBest results with daily 30-min sessions for 8+ weeks
Labor painModerate (Cochrane 2009)Reduces pharmacological analgesia need
Chronic neuropathic pain (general)MixedOften used as adjunct; responder identification unclear

How a TENS electrode patch is engineered

The electrode patch has three functional layers: a current-distribution layer (carbon-loaded polymer or silver/silver-chloride coating), a hydrogel adhesive layer (conductive, hypoallergenic), and a release liner (peeled before application). The patch connects to the TENS controller via a snap connector or a tab lead wire.

LayerMaterialFunction
Current-distribution layerCarbon-loaded silicone or Ag/AgCl coatingUniform current spread across patch surface
Hydrogel adhesivePolyacrylamide or karaya gum hydrogel, conductiveSkin adhesion + ionic conduction path
Backing substratePolyester film or non-woven fabricMechanical support; dielectric insulation
Snap connectorStainless steel or nickel-plated brassConnection to TENS lead wire
Release linerPET film, silicone-coatedProtects hydrogel until use

Where on the body should TENS electrodes be placed — and where should they be avoided?

Body areaApplyAvoid
Paravertebral muscles (cervical, thoracic, lumbar)Yes - bilateral placement over affected dermatomeAvoid over the spine midline
Trapezius / shoulderYes - parallel to muscle fibersAvoid the supraclavicular fossa
Knee (medial / lateral)Yes - around joint lineAvoid over the patella directly
Lower abdomen (dysmenorrhea)Yes - suprapubic placementAvoid during pregnancy
Calves / forearmsYes - post-exercise DOMSAvoid over fractured bones
Anterior neck / carotid sinusNoAlways avoid - vagal stimulation risk
Across the eyes / templesNoAlways avoid
Over heart (transverse)NoAlways avoid (without cardiologist guidance)
Over pacemaker / implanted defibrillatorNoAlways avoid
Broken skin, irritated skinNoAlways avoid

B2B spec sheet: factory-direct TENS electrode patch

ParameterStandard specCustomization available
Patch shapeRectangular 5 x 9 cm, round 5 cm diameter, butterfly 7 x 13 cmCustom die-cut shapes available
Current-distribution layerCarbon-loaded silicone or Ag/AgCl coatingPremium Ag/AgCl for higher uniformity
HydrogelPolyacrylamide, conductive, hypoallergenicKaraya gum for sensitive skin
Impedance (1 kHz)Less than 50 ohms across patch surfaceTighter specs for clinical use
Snap connectorStandard 3.5 mm or 4 mm pin, stainless steelPinned or tab connector alternatives
Reuse cycles20-50 applications with proper careSingle-use sterile version available
Shelf life24-36 months sealed (hydrogel dries out after opening)Resealable pouch extends post-open life
MOQ10,000 patches (standard shape)50,000 for custom die-cut shapes
Lead time30-45 days after artwork approvalAdd 15-30 days for custom tooling
CertificationsISO 13485, CE MDR Class IIa, FDA 510(k) for finished deviceSite audit on request
Packaging2 / 4 / 6 / 8 patch resealable pouchRetail-ready cartons with IFU

How to source a TENS electrode patch from an OEM factory

  1. Request sample - order 20-50 patches in standard shapes (rectangular 5 x 9 cm, round 5 cm, butterfly 7 x 13 cm) for in-house testing. Most factories deliver samples within 7 days.
  2. Pilot run (1,000-5,000 pcs) - confirm impedance uniformity, adhesion wear-time, and snap-connector compatibility with your TENS controller.
  3. Bulk production (10,000+ pcs) - full GMP batch with impedance QC records, electrode traceability, and FDA 510(k) / CE MDR technical file support. Lead time 30-45 days for stock shapes.

Henan Hanmeng Bio-Tech runs all three steps in-house at its GMP-certified facility in Henan, China, with ISO 13485 quality management and full support for FDA 510(k), CE MDR Class IIa, and NMPA filing for finished TENS electrode-patch devices. Custom die-cut shapes, hydrogel formulations, and snap-connector variants are available on every production tier.

For the full TENS electrode patch spec sheet — including shape options, impedance targets, and OEM-bundled controller-pairing — visit the Henan Hanmeng Bio-Tech TENS electrode OEM page.

CONTACT US

QQ: 396269538

Phone: 17796669065

Tel: 17796669065

Email: 396269538

Add: Room 001, 1st Floor, Building 1, Zhengzhou Hangmei International Smart City, Intersection of S102 and Nanquan Road, Xuedian Town, Xinzheng City, Zhengzhou, Henan Province, China